menu
    • menu

    Company profile for Cytoreason

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    With one of the world’s largest libraries of human molecular data, and a platform to make that data accessible and useful, CytoReason is able to turn data into actionable biological insights for use in clinical and pre-clinical drug development programs. CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients,...
    With one of the world’s largest libraries of human molecular data, and a platform to make that data accessible and useful, CytoReason is able to turn data into actionable biological insights for use in clinical and pre-clinical drug development programs. CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients, at the right time.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytoreasonIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Floor 16, Round Building, Azrieli Center, Menachem Begin 132, Tel Aviv 67012
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cytoreason.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytoreason/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Cytoreason

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytoreason Introduces LINA, AI Agent Powered By NVIDIA
    Cytoreason Introduces LINA, AI Agent Powered By NVIDIA

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cytoreason-unveils-lina-an-ai-agent-accelerated-by-nvidia-for-pharma-rd-built-on-computational-disease-models-302658468.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    Cytoreason Expands Sanofi Partnership For AI Drug Discovery
    Cytoreason Expands Sanofi Partnership For AI Drug Discovery

    10 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cytoreason-extends-its-collaboration-with-sanofi-to-advance-ai-driven-drug-discovery-302657269.html

    PR NEWSWIRE
    10 Jan 2026
    Share Share
    CytoReason Raises $80M To Scale AI Models And Open US Hub
    CytoReason Raises $80M To Scale AI Models And Open US Hub

    17 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240717912688/en

    BUSINESSWIRE
    17 Jul 2024
    Share Share
    CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance
    CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance

    23 Jan 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-01-23/cytoreason-licenses-ibd-disease-model-to-sanofi-in-expanded-alliance/?widget=listSection

    CONTRACT PHARMA
    23 Jan 2023
    Share Share
    CytoReason, Pfizer ink $110M extension of AI collab
    CytoReason, Pfizer ink $110M extension of AI collab

    21 Sep 2022

    // Andrea Park FIERCEBIOTECH

    https://www.fiercebiotech.com/medtech/cytoreason-pfizer-ink-110m-five-year-extension-ai-powered-drug-development-deal

    Andrea Park FIERCEBIOTECH
    21 Sep 2022
    Share Share
    CytoReason Announces Expanded Collaboration Deal with Pfizer
    CytoReason Announces Expanded Collaboration Deal with Pfizer

    20 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/20/2519131/0/en/CytoReason-Announces-Expanded-Collaboration-Deal-with-Pfizer-to-Deliver-AI-for-Drug-Discovery-and-Development.html

    GLOBENEWSWIRE
    20 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search